Skip to content

Comparative effectiveness of a mindfulness-based intervention (M-Body) on depressive symptoms: study protocol of a randomized controlled trial in a Federally Qualified Health Center (FQHC).

Inger Burnett-Zeigler, Elayne Zhou, Jennifer H Martinez, Katelyn Zumpf, Lynette Lartey, Judith T. Moskowitz, Katherine L Wisner, Thomas McDade, C Hendricks Brown, Jacqueline Gollan, Jody D Ciolino, Jacob M Schauer, Lucia C Petito

Trials February 17, 2023 DOI: 10.1186/s13063-022-07012-2 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial (study protocol) Peer reviewed
Sample size 274
Population English-speaking adults aged 18-65 with depressive symptoms, predominantly Black women, recruited at a Federally Qualified Health Center in a metropolitan city
Interventions Mindfulness-based intervention (M-Body) enhanced usual care
Duration 8-week intervention; assessments at baseline and 2, 4, and 6 months after baseline
Topics Meditation
Keywords Community health Depression treatment Disparities Health equity
Registration NCT03620721
Key findings The protocol outlines a two-armed, stratified, individually randomized group-treated controlled trial comparing eight weekly 90-minute group sessions of a mindfulness-based intervention (M-Body) with enhanced usual care among 274 adults with depressive symptoms. The authors propose that if M-Body is effective, it could increase access to mental health treatment in underserved racial and ethnic minority communities.

Abstract

Mindfulness-based interventions have been shown to improve psychological outcomes including stress, anxiety, and depression in general population studies. However, effectiveness has not been sufficiently examined in racially and ethnically diverse community-based settings. We will evaluate the effectiveness and implementation of a mindfulness-based intervention on depressive symptoms among predominantly Black women at a Federally Qualified Health Center in a metropolitan city. In this 2-armed, stratified, individually randomized group-treated controlled trial, 274 English-speaking participants with depressive symptoms ages 18-65 years old will be randomly assigned to (1) eight weekly, 90-min group sessions of a mindfulness-based intervention (M-Body), or (2) enhanced usual care. Exclusion criteria include suicidal ideation in 30 days prior to enrollment and regular (>4x/week) meditation practice. Study metrics will be assessed at baseline and 2, 4, and 6 months after baseline, through clinical interviews, self-report surveys, and stress biomarker data including blood pressure, heart rate, and stress related biomarkers. The primary study outcome is depressive symptom score after 6 months. If M-Body is found to be an effective intervention for adults with depressive symptoms, this accessible, scalable treatment will widely increase access to mental health treatment in underserved, racial/ethnic minority communities. ClinicalTrials.gov NCT03620721. Registered on 8 August 2018.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics